Institution Directory

Clinical trials at University of Chicago Medicine

Sites in Chicago, IL

Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 11:14 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials

1117

Shown on this page

Current sort

Live official records

Conditions: Right Bundle-Branch Block, Heart Failure, His-bundle Pacing, Cardiac Resynchronization Therapy
Interventions: His-CRT implantation, BIV-CRT implantation; Procedure
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 14
States / cities: Phoenix, Arizona • Los Angeles, California • Tampa, Florida + 8 more

Conditions: Multiple Pathologies
Interventions: Endovascular aortic repair; Device
Lead sponsor: W.L.Gore & Associates; Industry
Eligibility: Not listed
Enrollment: 4,600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2027
U.S. locations: 2
States / cities: Chicago, Illinois • Plano, Texas

Conditions: Urge Incontinence, Urgency-frequency Syndrome, Overactive Bladder
Interventions: Sacral neuromodulation; Procedure
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older · Female only
Enrollment: 193 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Interventions: Biospecimen Collection, Vincristine; Procedure · Drug
Lead sponsor: Children's Oncology Group; Network
Eligibility: Up to 12 Years
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 27
States / cities: Birmingham, Alabama • Los Angeles, California • Orange, California + 23 more

Conditions: Oropharyngeal Cancer
Interventions: Toripalimab, Carboplatin, Paclitaxel; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2033
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Tibial Plateau Fractures
Interventions: Bupivacain; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: AAA - Abdominal Aortic Aneurysm
Interventions: Not listed
Lead sponsor: W.L.Gore & Associates; Industry
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2042
U.S. locations: 45
States / cities: Little Rock, Arkansas • Irvine, California • Los Angeles, California + 38 more

Conditions: Carpal Tunnel Syndrome, Perioperative/Postoperative Complications
Interventions: Polarcare Machine, Standard of care ice therapy; Other
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Diabetes Mellitus, Neuropathy, Neuropathic Pain, Vascular Diseases, Vascular Stiffness, Microvascular Changes, Pain, Chronic
Interventions: Not listed
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Spinocerebellar Ataxia
Interventions: Not listed
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 75 Years
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Menopausal, Dementia
Interventions: PERI-MIND; Behavioral
Lead sponsor: University of Chicago; Other
Eligibility: 40 Years to 58 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: FSGS
Interventions: DMX-200, Placebo; Drug
Lead sponsor: Dimerix Bioscience Pty Ltd; Industry
Eligibility: 12 Years to 80 Years
Enrollment: 286 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2029
U.S. locations: 54
States / cities: Birmingham, Alabama • Phoenix, Arizona • Loma Linda, California + 44 more

About this University of Chicago Medicine institution page

What this page lists: ClinicalTrials.gov records that list University of Chicago Medicine in Chicago, IL as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status: A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from: Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do: No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.

Clinical trials at University of Chicago Medicine

Filter and sort this campus

Live official records

His-Bundle Corrective Pacing in Heart Failure

Global Registry for Endovascular Aortic Treatment (GREAT)

Percutaneous Nerve Evaluation Trial Time

Vincristine Pharmacokinetics in Infants

Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer

Genicular Nerve Block After Open Reduction Internal Fixation of Tibial Plateau

Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis

Effect of Cooling Therapy for Post-Operative Pain in Open Carpal Tunnel Release

Diabetic Neuropathy in Spinal Cord Stimulator Patients

Wearable Gait Sensors

Development of a Personalized, Psychosocial Intervention for Menopausal Individuals With Elevated Dementia Risk

A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB

About this University of Chicago Medicine institution page